GLP-1 receptor agonists in cardiovascular disease: a guide for cardiologists
British Journal of Cardiology · 2026
DOI: 10.5837/bjc.2026.038 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Cardiology, 2026. Verfasst von Sarah L Ayton und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Fellow, Department of Cardiovascular Sciences and British Heart Foundation Centre of Research Excellence, University of Leicester a…. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Obesity is a global epidemic, which, directly and indirectly, contributes to almost all cardiovascular diseases, including atherosclerotic cardiovascular disease, heart failure and atrial fibrillation. Reduction of weight is associated with substantial improvements in cardiometabolic risk factors, including blood pressure and glycaemic control, with over 10% weight loss required to see improvement in rates of major adverse cardiovascular events. Glucagon-like peptide-1 (GLP-1) receptor agonists have changed the landscape of type 2 diabetes and obesity management, showing significant benefit in glycaemic control and weight loss. Their potential for cardiovascular benefits means that they will likely have a central role in the management of patients with obesity-related cardiovascular diseases. This review summarises currently available GLP-1-based pharmacotherapies and highlights recent trials demonstrating cardiovascular benefits, and also provides practical guidance for patient selection, available agents, their initiation and patient monitoring. This will serve as an aid for cardiovascular clinicians, who will inevitably encounter patients suitable for, or already using, these drugs in their daily practice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Research Fellow, Department of Cardiovascular Sciences and British Heart Foundation Centre of Research Excellence, University of Leicester and the NIHR Leicester Biomedical Research Centre, Glenfield Hospital,…
- Associate Professor and Honorary Consultant in Diabetes and Endocrinology, Leicester Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester; Department of Diabetes and Endocrinology, Ke…
- Professor of Diabetes Medicine, Leicester Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester.
- Professor of Cardiac Imaging and Honorary Consultant Cardiologist, Department of Cardiovascular Sciences and British Heart Foundation Centre of Research Excellence, University of Leicester and the NIHR Leicester Biomedi…
- Academic Clinical Lecturer, Department of Cardiovascular Sciences and British Heart Foundation Centre of Research Excellence, University of Leicester and the NIHR Leicester Biomedical Research Centre, Glenfield Hospital…
Zitieren
APA
Ayton, S. L., Papamargaritis, D., Davies, M. J., McCann, G. P., & Gulsin, G. S. (2026). GLP-1 receptor agonists in cardiovascular disease: a guide for cardiologists. British Journal of Cardiology. https://doi.org/10.5837/bjc.2026.038
Vancouver
Ayton SL, Papamargaritis D, Davies MJ, McCann GP, Gulsin GS. GLP-1 receptor agonists in cardiovascular disease: a guide for cardiologists. British Journal of Cardiology. 2026. doi:10.5837/bjc.2026.038
BibTeX
@article{Ayton2026,
author = {Ayton, Sarah L and Papamargaritis, Dimitris and Davies, Melanie J and McCann, Gerry P and Gulsin, Gaurav S},
title = {GLP-1 receptor agonists in cardiovascular disease: a guide for cardiologists},
journal = {British Journal of Cardiology},
year = {2026},
doi = {10.5837/bjc.2026.038}
}
EUVIMED